In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

Input: Consider Input: (Sec. 3) Directs the Comptroller General, in order to determine the degree to which China is complying with its WTO commitments and to obtain information about any problems encountered by U.S. businesses, to survey annually and report to Congress on the 50 U.S. companies doing the most business with China in exporting nonagricultural and agricultural goods, exporting or providing services, investing, or importing goods. Directs the International Trade Commission to report annually to Congress on United States-China bilateral export and import statistics, including, to the extent practicable, reconciling any differences in U.S.-source and Chinese-source data.
(Sec. 4) Directs the United States Trade Representative (USTR), not later than one year after China accedes to the WTO, and annually thereafter, to report to Congress on China's compliance with its commitments under the WTO, including both multilateral commitments and any bilateral commitments made to the United States.
(Sec. 5) Authorizes specified congressional committees to instruct the USTR to: (1) take appropriate trade relief action after initiating an investigation under the Trade Act of 1974 to determine if U.S. rights under any agreement are being denied, or an act, policy, or practice of China violates the provisions of, or otherwise denies benefits to the United States under, any trade agreement, or is unjustifiable and burdens or restricts U.S. commerce; or (2) initiate action before the Dispute Settlement Body of the WTO. Amends the Trade Act of 1974 to authorize the USTR, for purposes of making an affirmative determination with respect to an investigation, to draw an inference adverse to the interest of a country that fails or refuses to cooperate in the investigation. Directs the USTR, if he or she makes an affirmative determination with respect to China, to initiate an action before the Dispute Settlement Body, unless there exists another, more effective action.
(Sec. 6) Expresses the sense of Congress that there should be a special multilateral process at the WTO for conducting an annual review of China's compliance with the commitments it makes as part of its accession to the WTO. Directs the USTR to propose that: (1) as part of the Trade Policy Review Mechanism of the WTO, a thorough review of China's trade policies be conducted each year; (2) the Trade Policy Review Mechanism be significantly enhanced and expanded in connection with the review of China; and (3) the Trade Policy Review Mechanism of China include onsite visits and active participation by representatives of WTO members.
(Sec. 7) Directs the President to submit to Congress a plan for providing assistance to China to build the institutions necessary to carry out the obligations China has made as part of its accession to the WTO. Authorizes appropriations.

Output: China-World Trade Organization Compliance Act


Input: Consider Input: Deposit Insurance Fairness and Economic Opportunity Act - Amends the Federal Deposit Insurance Act to direct the Board of Directors of the Federal Deposit Insurance Corporation to distribute in the form of a dividend any excess amounts remaining from semiannual assessments imposed upon insured depository institutions (excess deposit insurance funds).

Defines excess amounts as the amount of funds exceeding 1.40 percent of the total estimated deposits insured by theBank Insurance Fund or the Savings Association Insurance Fund.

Output: A bill to amend the Federal Deposit Insurance Act to provide for the return of excess amounts in Federal deposit insurance funds to financial institutions for use in their communities, with such distributions allocated according to the historical basis of contributions made to the funds by such institutions.


Input: Consider Input: FDA Deeming Authority Clarification Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to: (1) revise premarket review and reporting requirements for products newly deemed by the Food and Drug Administration (FDA) to be tobacco products; and (2) grant the FDA the authority to regulate vapor products, which include products that produce vapor with nicotine (e.g., e-cigarettes) and nicotine intended to be used with such a product (e.g., nicotine cartridges). A product is not subject to premarket review by the FDA if it is marketed before it is deemed a tobacco product. The bill delays deadlines for reports to the FDA on products similar to a marketed product that are introduced to market less than 21 months after that type of product is deemed a tobacco product. The bill grants the FDA regulatory authority over vapor products that is in addition to the FDA's existing authority to regulate vapor products as tobacco products. Provisions of the FFDCA applicable to tobacco product components also apply to vapor product batteries. The FDA must establish standards for vapor product batteries. Vapor products first marketed not later than 24 months after enactment of this bill are not subject to premarket review or reporting requirements based on changes to the product's battery to conform to standards. Vapor products may not be advertised in publications, except publications with adult readership. Vapor products may be sold only face-to-face, through vending machines in facilities where only adults are permitted, or by mail order. Vapor products must be labeled with their nicotine content and specified phrases. Retailers of vapor products must register with the FDA.


Output: FDA Deeming Authority Clarification Act of 2017